Machinaga A - Search Results

1

Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models.

Nakazawa Y, Miyano M, Tsukamoto S, Kogai H, Yamamoto A, Iso K, Inoue S, Yamane Y, Yabe Y, Umihara H, Taguchi J, Akagi T, Yamaguchi A, Koga M, Toshimitsu K, Hirayama T, Mukai Y, Machinaga A. Nakazawa Y, et al. Among authors: machinaga a. Nat Commun. 2024 Mar 11;15(1):2192. doi: 10.1038/s41467-024-46167-1. Nat Commun. 2024. PMID: 38467634 Free PMC article.

2

Blockage of retinoic acid signaling via RARγ suppressed the proliferation of pancreatic cancer cells by arresting the cell cycle progression of the G1-S phase.

Yamakawa K, Koyanagi-Aoi M, Machinaga A, Kakiuchi N, Hirano T, Kodama Y, Aoi T. Yamakawa K, et al. Among authors: machinaga a. Cancer Cell Int. 2023 May 17;23(1):94. doi: 10.1186/s12935-023-02928-4. Cancer Cell Int. 2023. PMID: 37198667 Free PMC article.

3

Cell-matrix interface regulates dormancy in human colon cancer stem cells.

Ohta Y, Fujii M, Takahashi S, Takano A, Nanki K, Matano M, Hanyu H, Saito M, Shimokawa M, Nishikori S, Hatano Y, Ishii R, Sawada K, Machinaga A, Ikeda W, Imamura T, Sato T. Ohta Y, et al. Among authors: machinaga a. Nature. 2022 Aug;608(7924):784-794. doi: 10.1038/s41586-022-05043-y. Epub 2022 Jul 7. Nature. 2022. PMID: 35798028

4

Xenografts Derived From Patients' Ascites Recapitulate the Gemcitabine Resistance Observed in Pancreatic Cancer Patients.

Machinaga A, Hori Y, Shimizu K, Okahara K, Yanagita E, Miyoshi M, Itoh T, Sasai K. Machinaga A, et al. Pancreas. 2019 Nov/Dec;48(10):1294-1302. doi: 10.1097/MPA.0000000000001438. Pancreas. 2019. PMID: 31688592

5

Inhibition of the Progression of Skin Inflammation, Fibrosis, and Vascular Injury by Blockade of the CX₃ CL1/CX₃ CR1 Pathway in Experimental Mouse Models of Systemic Sclerosis.

Luong VH, Utsunomiya A, Chino T, Doanh LH, Matsushita T, Obara T, Kuboi Y, Ishii N, Machinaga A, Ogasawara H, Ikeda W, Kawano T, Imai T, Oyama N, Hasegawa M. Luong VH, et al. Among authors: machinaga a. Arthritis Rheumatol. 2019 Nov;71(11):1923-1934. doi: 10.1002/art.41009. Epub 2019 Sep 11. Arthritis Rheumatol. 2019. PMID: 31173491

6

Splicing of Friend Murine Leukemia Virus env-mRNA Enhances Its Ability to Form Polysomes.

Machinaga A, Ishihara S, Shirai A, Takase-Yoden S. Machinaga A, et al. Front Microbiol. 2016 Feb 16;7:160. doi: 10.3389/fmicb.2016.00160. eCollection 2016. Front Microbiol. 2016. PMID: 26909075 Free PMC article.

7

Polyadenylation of Friend murine leukemia virus env-mRNA is affected by its splicing.

Machinaga A, Takase-Yoden S. Machinaga A, et al. Microbiol Immunol. 2014 Aug;58(8):474-82. doi: 10.1111/1348-0421.12170. Microbiol Immunol. 2014. PMID: 24935657 Free article.

8

A 38 nt region and its flanking sequences within gag of Friend murine leukemia virus are crucial for splicing at the correct 5' and 3' splice sites.

Machinaga A, Takase-Yoden S. Machinaga A, et al. Microbiol Immunol. 2014 Jan;58(1):38-50. doi: 10.1111/1348-0421.12114. Microbiol Immunol. 2014. PMID: 24236664 Free article.

9

The 0.3-kb fragment containing the R-U5-5'leader sequence of Friend murine leukemia virus influences the level of protein expression from spliced mRNA.

Choo YC, Seki Y, Machinaga A, Ogita N, Takase-Yoden S. Choo YC, et al. Among authors: machinaga a. Virol J. 2013 Apr 19;10:124. doi: 10.1186/1743-422X-10-124. Virol J. 2013. PMID: 23602143 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page